Exosomal circRNA: emerging insights into cancer progression and clinical application potential

被引:0
作者
Fan Zhang
Jiajia Jiang
Hui Qian
Yongmin Yan
Wenrong Xu
机构
[1] Aoyang Institute of Cancer,Department of Laboratory Medicine
[2] Affiliated Aoyang Hospital of Jiangsu University,Zhenjiang Key Laboratory of High Technology Research on sEVs Foundation and Transformation Application, School of Medicine
[3] Wujin Hospital Affiliated with Jiangsu University,undefined
[4] Jiangsu University,undefined
来源
Journal of Hematology & Oncology | / 16卷
关键词
Exosome; circRNA; Tumor immunity; Tumor metabolism; Biomarker; Cancer therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Exosomal circRNA serves a novel genetic information molecule, facilitating communication between tumor cells and microenvironmental cells, such as immune cells, fibroblasts, and other components, thereby regulating critical aspects of cancer progression including immune escape, tumor angiogenesis, metabolism, drug resistance, proliferation and metastasis. Interestingly, microenvironment cells have new findings in influencing tumor progression and immune escape mediated by the release of exosomal circRNA. Given the intrinsic stability, abundance, and broad distribution of exosomal circRNAs, they represent excellent diagnostic and prognostic biomarkers for liquid biopsy. Moreover, artificially synthesized circRNAs may open up new possibilities for cancer therapy, potentially bolstered by nanoparticles or plant exosome delivery strategies. In this review, we summarize the functions and underlying mechanisms of tumor cell and non-tumor cell-derived exosomal circRNAs in cancer progression, with a special focus on their roles in tumor immunity and metabolism. Finally, we examine the potential application of exosomal circRNAs as diagnostic biomarkers and therapeutic targets, highlighting their promise for clinical use.
引用
收藏
相关论文
共 1004 条
[81]  
Wu ZJ(2023)A novel protein encoded by circINSIG1 reprograms cholesterol metabolism by promoting the ubiquitin-dependent degradation of INSIG1 in colorectal cancer Mol Cancer 22 951-2984
[82]  
Liu B(2023)Natural products in pursuing novel therapies of nonalcoholic fatty liver disease and steatohepatitis Drug Discov Today 28 1323-272
[83]  
Gao Y(2023)Unravelling the role of obesity and lipids during tumor progression Front Pharmacol 14 287-4511
[84]  
Pan Z(2019)Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7 Oncogene 38 470-238.e225
[85]  
Zhao R(2020)A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells Cell Metab 31 1054-109.e109
[86]  
Li B(2023)Circ_0000069 contributes to the growth, metastasis and glutamine metabolism in renal cell carcinoma (RCC) via regulating miR-125a-5p-dependent SLC1A5 expression Transpl Immunol 77 375-434.e426
[87]  
Qi Y(2022)Circ_0000808 promotes the development of non-small cell lung cancer by regulating glutamine metabolism via the miR-1827/SLC1A5 axis World J Surg Oncol 20 1078-13
[88]  
Qiu W(2022)circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis Cell Mol Biol Lett 27 8211-25
[89]  
Guo Q(2023)Circ_0067717 promotes colorectal cancer cell growth, invasion and glutamine metabolism by serving as a miR-497-5p sponge to upregulate SLC7A5 Histol Histopathol 38 20139-6436
[90]  
Hu Z(2023)M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy Int J Biol Sci 19 437-1744.e1716